Literature DB >> 8892874

Enhanced transcriptional activation by E2 proteins from the oncogenic human papillomaviruses.

R Kovelman1, G K Bilter, E Glezer, A Y Tsou, M S Barbosa.   

Abstract

A systematic comparison of transcriptional activation by papillomavirus E2 proteins revealed that the E2 proteins from high-risk human papillomaviruses (human papillomavirus type 16 [HPV-16] and HPV-18) are much more active than are the E2 proteins from low-risk HPVs (HPV-6b and HPV-11). Despite the tropism of HPVs for particular epithelial cell types, this difference in transcriptional activation was observed in a number of different epithelial and nonepithelial cells. The enhanced activities of the E2 proteins from high-risk HPVs did not result from higher steady-state levels of protein in vivo, and in vitro DNA-binding assays revealed similar binding properties for these two classes of E2 proteins. These results demonstrate that the E2 proteins from high-risk HPVs have an intrinsically enhanced potential to activate transcription from promoters with E2-responsive elements. We found that there are also substantial differences between the activation properties of the bovine papillomavirus type 1 E2 protein and those of either of the two classes of HPV E2 proteins, especially with regard to requirements for particular configurations of E2 binding sites in the target promoter. Our results indicate that there are at least three distinct functional classes of E2 proteins and that these classes of E2 proteins may perform different roles during the respective viral life cycles.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8892874      PMCID: PMC190823     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  63 in total

Review 1.  The papillomavirus E2 protein: a factor with many talents.

Authors:  J Ham; N Dostatni; J M Gauthier; M Yaniv
Journal:  Trends Biochem Sci       Date:  1991-11       Impact factor: 13.807

2.  Interaction of the bovine papillomavirus type 1 E2 transcriptional control protein with the viral enhancer: purification of the DNA-binding domain and analysis of its contact points with DNA.

Authors:  C A Moskaluk; D Bastia
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

3.  Enhancers and trans-acting E2 transcriptional factors of papillomaviruses.

Authors:  H Hirochika; T R Broker; L T Chow
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

4.  Functional mapping of the human papillomavirus type 11 transcriptional enhancer and its interaction with the trans-acting E2 proteins.

Authors:  H Hirochika; R Hirochika; T R Broker; L T Chow
Journal:  Genes Dev       Date:  1988-01       Impact factor: 11.361

5.  Study of the E2 gene product of the cottontail rabbit papillomavirus reveals a common mechanism of transactivation among papillomaviruses.

Authors:  I Giri; M Yaniv
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

6.  Regulation of human papillomavirus type 11 enhancer and E6 promoter by activating and repressing proteins from the E2 open reading frame: functional and biochemical studies.

Authors:  M T Chin; R Hirochika; H Hirochika; T R Broker; L T Chow
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

7.  The carboxy-terminal domain shared by the bovine papillomavirus E2 transactivator and repressor proteins contains a specific DNA binding activity.

Authors:  A A McBride; R Schlegel; P M Howley
Journal:  EMBO J       Date:  1988-02       Impact factor: 11.598

8.  The BPV1-E2 trans-acting protein can be either an activator or a repressor of the HPV18 regulatory region.

Authors:  F Thierry; M Yaniv
Journal:  EMBO J       Date:  1987-11       Impact factor: 11.598

9.  Transcriptional regulation of the human papillomavirus-16 E6-E7 promoter by a keratinocyte-dependent enhancer, and by viral E2 trans-activator and repressor gene products: implications for cervical carcinogenesis.

Authors:  T P Cripe; T H Haugen; J P Turk; F Tabatabai; P G Schmid; M Dürst; L Gissmann; A Roman; L P Turek
Journal:  EMBO J       Date:  1987-12-01       Impact factor: 11.598

10.  The specific DNA recognition sequence of the bovine papillomavirus E2 protein is an E2-dependent enhancer.

Authors:  P Hawley-Nelson; E J Androphy; D R Lowy; J T Schiller
Journal:  EMBO J       Date:  1988-02       Impact factor: 11.598

View more
  25 in total

1.  Cooperative activation of human papillomavirus type 8 gene expression by the E2 protein and the cellular coactivator p300.

Authors:  Andreas Müller; Andreas Ritzkowsky; Gertrud Steger
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  Bromodomain protein 4 mediates the papillomavirus E2 transcriptional activation function.

Authors:  Michal-Ruth Schweiger; Jianxin You; Peter M Howley
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

3.  Brd4 is required for e2-mediated transcriptional activation but not genome partitioning of all papillomaviruses.

Authors:  M G McPhillips; J G Oliveira; J E Spindler; R Mitra; A A McBride
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

4.  Conserved interaction of the papillomavirus E2 transcriptional activator proteins with human and yeast TFIIB proteins.

Authors:  J D Benson; R Lawande; P M Howley
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

5.  Brd4-independent transcriptional repression function of the papillomavirus e2 proteins.

Authors:  Michal-Ruth Schweiger; Matthias Ottinger; Jianxin You; Peter M Howley
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

6.  Transactivation by the E2 protein of oncogenic human papillomavirus type 31 is not essential for early and late viral functions.

Authors:  F Stubenrauch; A M Colbert; L A Laimins
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

7.  The SMC5/6 Complex Interacts with the Papillomavirus E2 Protein and Influences Maintenance of Viral Episomal DNA.

Authors:  Peris Bentley; Min Jie Alvin Tan; Alison A McBride; Elizabeth A White; Peter M Howley
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

8.  Repression of the integrated papillomavirus E6/E7 promoter is required for growth suppression of cervical cancer cells.

Authors:  D A Francis; S I Schmid; P M Howley
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

9.  Cell-type specific transcriptional activities among different papillomavirus long control regions and their regulation by E2.

Authors:  Matthias Ottinger; Jennifer A Smith; Michal-Ruth Schweiger; Dana Robbins; Maria L C Powell; Jianxin You; Peter M Howley
Journal:  Virology       Date:  2009-12-20       Impact factor: 3.616

10.  Transcriptome signature of irreversible senescence in human papillomavirus-positive cervical cancer cells.

Authors:  Susanne I Wells; Bruce J Aronow; Trisha M Wise; Sarah S Williams; Jennifer A Couget; Peter M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.